BioCatalyst

Cetrelimab, TAR-200, Cisplatin, Gemcitabine — catalyst calendar

1 verified catalyst event(s) referencing Cetrelimab, TAR-200, Cisplatin, Gemcitabine, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-30
in 3mo
ESTIMATED
 READOUT
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradioth
Phase 3 · Urinary Bladder Neoplasms
 Janssen Research & Development, LL Cetrelimab, TAR-200, Cisplatin, Gemcitab ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.